We convened an ad hoc International Working Group for Antibody Validation in order to formulate the best approaches for validating antibodies used in common research applications and to provide guidelines that ensure antibody reproducibility. We recommend five conceptual 'pillars' for antibody validation to be used in an application-specific manner.
Subscribe to Journal
Get full journal access for 1 year
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Bordeaux, J. et al. Biotechniques 48, 197–209 (2010).
Baker, M. Nature 527, 545–551 (2015).
Bandrowski, A. et al. Neuroinformatics 14, 169–182 (2016).
Bourbeillon, J. et al. Nat. Biotechnol. 28, 650–653 (2010).
Bradbury, A. & Plückthun, A. Nature 518, 27–29 (2015).
Saper, C.B. J. Comp. Neurol. 493, 477–478 (2005).
Stadler, C. et al. J. Proteomics 75, 2236–2251 (2012).
Olds, W. & Li, J. F1000 Res. 5, 308 (2016).
Kanchiswamy, C.N., Maffei, M., Malnoy, M., Velasco, R. & Kim, J.S. Trends Biotechnol. 34, 562–574 (2016).
Carr, S.A. et al. Mol. Cell. Proteomics 13, 907–917 (2014).
Abbatiello, S.E. et al. Mol. Cell. Proteomics 14, 2357–2374 (2015).
Ebai, T., Kamali-Moghaddam, M. & Landegren, U. Curr. Protoc. Mol. Biol. 109, 20.10.1–20.10.25 (2015).
Lundberg, M., Eriksson, A., Tran, B., Assarsson, E. & Fredriksson, S. Nucleic Acids Res. 39, e102 (2011).
Juncker, D., Bergeron, S., Laforte, V. & Li, H. Curr. Opin. Chem. Biol. 18, 29–37 (2014).
Mahen, R. et al. Mol. Biol. Cell 25, 3610–3618 (2014).
Sander, J.D. & Joung, J.K. Nat. Biotechnol. 32, 347–355 (2014).
Stadler, C. et al. Nat. Methods 10, 315–323 (2013).
Marcon, E. et al. Nat. Methods 12, 725–731 (2015).
Sjöberg, R. et al. N. Biotechnol. 33, 582–592 (2016).
Jositsch, G. et al. Naunyn Schmiedebergs Arch. Pharmacol. 379, 389–395 (2009).
Author guidelines for J. Comp. Neurol. http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-9861/homepage/ForAuthors.html (accessed 11 April 2016).
The authors are responsible for all content and editorial decisions and received no honoraria related to the development of this publication. Editorial assistance in the preparation of this publication was provided by Phase Five Communications, supported by Thermo Fisher Scientific, which had no other involvement in the development of this publication.
M.U. is cofounder of Atlas Antibodies, Affibody Medical, and Antibodypedia. S.C. is a consultant to Biogen and PTM BioLabs Inc. A.B. is the founder of SciCrunch Inc., the technology backing for the Resource Identification Initiative. E.L. acknowledges formal links to Atlas Antibodies. D.L.R. is a consultant to Amgen, Applied Cellular Diagnostics, AstraZeneca, Agendia, Bethyl Labs, Biocept, BMS, Cernostics, FivePrime, Genoptix/Novartis, Metamark Genetics, MDAgree, OptraScan, and Perkin Elmer; he has received honoraria from Genentech/Roche and Ventana; and he acknowledges research support from Cepheid, Genoptix, Gilead Sciences, Kolltan, Perkin Elmer, and Nantomics. D.L.R. holds equity in MDAgree.
Integrated supplementary information
The fraction of publicly available antibodies toward human protein targets is shown with data for the following applications: Western blotting (WB), immunohistochemistry (IHC), immunocytochemistry (ICC), flow cytometry (FC), immunosorbent assays (ELISA), and immunoprecipitation (IP). The numbers are based on information from users and providers reported to the resource portal Antibodypedia7.
About this article
Cite this article
Uhlen, M., Bandrowski, A., Carr, S. et al. A proposal for validation of antibodies. Nat Methods 13, 823–827 (2016). https://doi.org/10.1038/nmeth.3995
Journal of Histochemistry & Cytochemistry (2020)
Mapping the nucleolar proteome reveals a spatiotemporal organization related to intrinsic protein disorder
Molecular Systems Biology (2020)
Analytical Biochemistry (2020)
Reviews in Aquaculture (2020)
Nucleic Acids Research (2020)